Gilead Sciences (NASDAQ:GILD)

Top Analyst Upgrades and Downgrades: Abbott Labs, CSX, IBM, Netflix, Occidental, Whiting, Amgen, Gilead, Merck, Pfizer and More

Stocks were indicated to open marginally higher on Thursday as the world appears to have better hopes for a Brexit framework out of Europe. Investors are having to grapple with ...
Read Full Story »

5 Raymond James Analyst Favorite Picks With Huge Implied Upside

For the first time in many years, active managers are outperforming index funds year to date, and that should be a loud wake-up call to passive investors. After a more ...
Read Full Story »

Short Sellers Hike Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, September 13. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, August 30. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Short Sellers Hike Their Bets in Biotech

The short interest data are out for the most recent settlement date, August 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

30 Sustainable Dividend Yields of 3.5% to Over 5% for Cautious Income Investors

It's a tricky world for income investors. There is currently around $15 trillion worth of government bonds trading at negative yields between Europe and Japan, and U.S. bond buyers have ...
Read Full Story »

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Over the past three decades, the unlimited investing potential of biotechnology was all about growth. Companies could grow from nothing to see untold billions of dollars selling cures and treatments ...
Read Full Story »

Short Sellers Make a Move on Big Biotechs

The short interest data are out for the most recent settlement date, July 31. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Altria, Apple, BP, EA, Enphase, FireEye, Gilead, Mastercard, P&G, 2U and More

Stocks saw profit-taking on Tuesday, but the major indexes were up on Wednesday ahead of the Federal Reserve's expected interest rate cut in the afternoon. Earnings season is proving to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Aflac, Apple, Chipotle, Coca-Cola, Dell, Dish, Gilead, McDonald’s, Starbucks and More

Stocks were indicated to have a slightly positive open on Monday, but the gains were so small that the outcome of the day seemed far from certain. A mixed earnings ...
Read Full Story »

Major Biotechs See Rising Tide in Short Interest

The short interest data are out for the most recent settlement date, July 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »

Meet Gilead’s Newest Collaboration

Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (NASDAQ: GLPG) each saw its shares shoot up on Monday after the companies announced a new collaboration. Under the terms of the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Agilent, Amazon, American Water Works, Crocs, Deere, GE, Gilead, Slack, Teva and More

Stocks were indicated to open marginally higher on Monday, with the indexes effectively at all-time highs based on communication from Federal Reserve Chair Jerome Powell that the agency is expected ...
Read Full Story »

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the most recent settlement date, June 28. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »